NCT06008119 2025-09-18Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal CancerShanghai Kechow Pharma, Inc.Phase 3 Recruiting165 enrolled
NCT01571284 2018-04-17Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based RegimenSanofiPhase 3 Completed781 enrolled 28 charts